ICH M9 guideline on biopharmaceutics classification system-based biowaivers

We have adopted this International Scientific Guideline - ICH M9; EMA/CHMP/ICH/493213/2018

Last updated

17 July 2024

About this guideline

Adopted by the TGA: 26 June 2024

Overseas effective date: 30 July 2020

Categories: ICH | Multidisciplinary

TGA annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types